Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Real World Observational Study of Naloxegol for Patients With Cancer Pain Diagnosed With Opioid Induced Constipation.

NCT03638440 is registered in ClinicalTrials.gov with Kyowa Kirin Pharmaceutical Development Ltd as lead sponsor.

NCT NCT03638440
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03638440 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Real World Observational Study of Naloxegol for Patients With Cancer Pain Diagnosed With Opioid Induced Constipation.
Lead sponsor
Kyowa Kirin Pharmaceutical Development Ltd
Phase
Observational
Overall status
Completed
Start date
August 16, 2018
Completion date
March 5, 2020
Enrollment
183 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

opioid induced constipation